# LOQTEQ® Antibacterial Pre-Market Study

> **NCT05260463** · NA · COMPLETED · sponsor: **aap Implantate AG** · enrollment: 203 (actual)

## Conditions studied

- Fractures, Open
- Fractures, Closed
- Surgical Site Infection
- Fracture of Fibula

## Interventions

- **DEVICE:** Implantation

## Key facts

- **NCT ID:** NCT05260463
- **Lead sponsor:** aap Implantate AG
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-12-09
- **Primary completion:** 2025-08-04
- **Final completion:** 2025-08-04
- **Target enrollment:** 203 (ACTUAL)
- **Last updated:** 2025-09-18

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05260463

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05260463, "LOQTEQ® Antibacterial Pre-Market Study". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT05260463. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
